2024-511537-35-00
CTIS ↗
Lutetium (177Lu) rhPSMA-10.1 injection
Metastatic castration-resistant prostate cancer (mCRPC)
pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection
Blue Earth Diagnostics
Blue Earth Diagnostics Ireland Ltd
Blue Earth Diagnostics trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB HQ
2014 Founded
120 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
- Founded
- 2014
- Employees
- 120
- Programs
- 11
- Drugs
- 12
- Patents
- 0
Blue Earth Diagnostics clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Blue Earth Diagnostics programs — each row shows trial ID, program name, phase, status, and indication.
Blue Earth Diagnostics trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Blue Earth Diagnostics.
-
BS-03 — Phase 1
Clinical update -
BS-02 — Phase 1
Clinical update -
BET-PSMA-001 — Phase 1
Clinical update -
Lutetium (177Lu) rhPSMA-10.1 injection — Phase 2
Clinical update -
Placebo, BFB759 — Phase 2
Clinical update -
BFB759, Placebo — Phase 2
Clinical update -
[68Ga]BED003 injection — Phase 2
Clinical update -
BJT-778 — Phase 3
Clinical update
Trial registry
-
-
CTIS ↗ - 2024-515264-31-00CTIS ↗
BET-PSMA-001
PSMA-positive non-curative metastatic castration-resistant prostate cancer
- 2024-515535-30-00CTIS ↗
BS-02
Treatment of human papilloma virus (HPV) associated infections, precancers and cancers
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2025-521983-36-00CTIS ↗
[68Ga]BED003 injection
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗